{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["24"],"submitter":["Li J"],"pubmed_abstract":["Tumor recurrence and tissue regeneration are two major challenges in the postoperative treatment of cancer. Current research hotspots are focusing on developing novel scaffold materials that can simultaneously suppress tumor recurrence and promote tissue repair. Here, we propose a microfluidic 3D-printed methacrylate fish gelatin (F-GelMA@BBR) scaffold loaded with berberine (BBR) for the postoperative treatment of gastric cancer. The F-GelMA@BBR scaffold displayed a significant killing effect on gastric cancer MKN-45 cells in vitro and demonstrated excellent anti-recurrence efficiency in gastric cancer postoperative models. In vitro experiments have shown that F-GelMA@BBR exhibits significant cytotoxicity on gastric cancer cells while maintaining the cell viability of normal cells. The res"],"journal":["Materials today. Bio"],"pagination":["100911"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10770549"],"repository":["biostudies-literature"],"pubmed_title":["Microfluidic printed 3D bioactive scaffolds for postoperative treatment of gastric cancer."],"pmcid":["PMC10770549"],"pubmed_authors":["Jiang Y","Li J","Shen X","Zhu T","Zhang Q","Zu Y"],"additional_accession":[]},"is_claimable":false,"name":"Microfluidic printed 3D bioactive scaffolds for postoperative treatment of gastric cancer.","description":"Tumor recurrence and tissue regeneration are two major challenges in the postoperative treatment of cancer. Current research hotspots are focusing on developing novel scaffold materials that can simultaneously suppress tumor recurrence and promote tissue repair. Here, we propose a microfluidic 3D-printed methacrylate fish gelatin (F-GelMA@BBR) scaffold loaded with berberine (BBR) for the postoperative treatment of gastric cancer. The F-GelMA@BBR scaffold displayed a significant killing effect on gastric cancer MKN-45 cells in vitro and demonstrated excellent anti-recurrence efficiency in gastric cancer postoperative models. In vitro experiments have shown that F-GelMA@BBR exhibits significant cytotoxicity on gastric cancer cells while maintaining the cell viability of normal cells. The res","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Feb","modification":"2025-04-18T18:45:33.267Z","creation":"2025-02-19T05:00:36.228Z"},"accession":"S-EPMC10770549","cross_references":{"pubmed":["38188649"],"doi":["10.1016/j.mtbio.2023.100911"]}}